| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2567588 | Pulmonary Pharmacology & Therapeutics | 2008 | 9 Pages |
Abstract
The combination of sildenafil and inhaled treprostinil was well tolerated and induced additive, pulmonary selective vasodilatation in pulmonary hypertension patients. This could be of relevance also for long-term treatment of PAH and CTEPH patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Robert Voswinckel, Frank Reichenberger, Beate Enke, Andre Kreckel, Stefanie Krick, Henning Gall, Ralph Theo Schermuly, Friedrich Grimminger, Lewis J. Rubin, Horst Olschewski, Werner Seeger, Hossein A. Ghofrani,